Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
AFLURIA QUAD (Seqirus Pty Ltd)
Product name
AFLURIA QUAD
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
200 working days (255)
Active ingredients
inactivated quadrivalent influenza vaccine (split virion)
Registration type
EOI
Indication
AFLURIA QUAD is now also indicated for the prevention of influenza caused by Influenza Virus, Types A and B contained in the vaccine, in persons aged 5-17 years.